The Impact of Changes in Clinical Guideline on Practice Patterns and Healthcare Utilizations for Kawasaki Disease in Japan

• Hauptverfasser: Yusuke Okubo (Verfasst von), Masaru Miura (Verfasst von), Tohru Kobayashi (Verfasst von), Naho Morisaki (Verfasst von), Nobuaki Michihata (Verfasst von), Hiroki Matsui (Verfasst von), Kiyohide Fushimi (Verfasst von), Hideo Yasunaga (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2020-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objective: Previous studies showed the efficacy of glucocorticoids on prevention of coronary artery lesions (CAL) among Kawasaki disease (KD) patients, and clinical guideline for KD in Japan was changed regarding glucocorticoid use in 2012. However, little is known regarding how the guideline change...